All In Biotech

Drug Trial Radar · NCT06154252

RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

A Phase 1/2, Open-Label Study to Evaluate the Safety and Efficacy of Autologous CD19-specific Chimeric Antigen Receptor T Cells (CABA-201) in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

Last checked: Nov 19, 2026Latest source record: Nov 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

74

Planned (sponsor's estimate)

Start

Dec 20, 2023

Primary completion

Jul 2028

Study completion Jul 2028

Sponsor

Lead sponsor
Cabaletta BioIndustry
Sponsor type
Industry
First posted
Dec 4, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 6 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

RESET-Myositis: Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects with Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

Conditions

  • Idiopathic Inflammatory Myopathy
  • Dermatomyositis
  • Anti-Synthetase Syndrome
  • Immune-Mediated Necrotizing Myopathy
  • Juvenile Dermatomyositis
  • Juvenile Polymyositis
  • Juvenile Idiopathic Inflammatory Myopathy (JIIM)
  • Juvenile Myositis

Interventions

  • CABA-201 following preconditioning with fludarabine and cyclophosphamideBiological

    Single intravenous infusion of CABA-201 at a single dose level following preconditioning with fludarabine and cyclophosphamide

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Phase 1/2: Incidence and severity of adverse events (AEs)Time frame: Up to 28 days after CABA-201 infusion
  2. Phase 2b Sub-study 1: Proportion of DM & ASyS subjects achieving at least a moderate Total Improvement Score (TIS) without any immunomodulatory medications and no or low dose of steroidsTime frame: Within 16 weeks
  3. Phase 2b Sub-study 2: Proportion of subjects with IMNM achieving at least a minimal TIS without any immunomodulatory medications and no or low dose of steroidsTime frame: Within 24 weeks

Locations

38 sites in 4 countries. Site status is shown where the registry gives one.

  • University of California Irvine - Accepting Adult Patients

    Orange, California · Recruiting

  • University of California, San Francisco Benioff Children's Hospital - Accepting Young Adult and Juvenile Patients

    San Francisco, California · Recruiting

  • Children's Hospital Colorado - Accepting Juvenile Patients

    Aurora, Colorado · Recruiting

  • Mayo Clinic Florida - Accepting Adult Patients

    Jacksonville, Florida · Recruiting

  • Johns Hopkins All Children's Hospital - Accepting Juvenile Patients

    St. Petersburg, Florida · Recruiting

  • Children's Healthcare of Atlanta - Accepting Juvenile Patients

    Atlanta, Georgia · Recruiting

  • Emory University - Accepting Adult Patients

    Atlanta, Georgia · Recruiting

  • Ann & Robert H. Lurie Children's Hospital of Chicago - Accepting Young Adult and Juvenile Patients

    Chicago, Illinois · Recruiting

  • Northwestern Memorial Hospital - Accepting Adult Patients

    Chicago, Illinois · Recruiting

  • The University of Chicago Medical Center - Accepting Adult and Juvenile Patients

    Chicago, Illinois · Recruiting

  • University of Kansas Medical Center - Accepting Adult Patients

    Kansas City, Kansas · Recruiting

  • National Institutes of Health - Accepting Adult and Juvenile Patients

    Bethesda, Maryland · Recruiting

  • Boston Children's Hospital - Accepting Young Adults and Juvenile Patients

    Boston, Massachusetts · Recruiting

  • University of Michigan - Accepting Young Adult and Juvenile Patients

    Ann Arbor, Michigan · Recruiting

  • Mayo Clinic - Accepting Adult Patients

    Rochester, Minnesota · Recruiting

  • Hospital for Special Surgery - Accepting Adult and Juvenile Patients

    New York, New York · Recruiting

  • Memorial Sloan Kettering Cancer Center - Accepting Adult and Juvenile Patients

    New York, New York · Recruiting

  • Children's Hospital at Montefiore - Accepting Young Adult and Juvenile Patients

    The Bronx, New York · Recruiting

  • University of North Carolina at Chapel Hill - Accepting Adult Patients

    Chapel Hill, North Carolina · Recruiting

  • Duke University Medical Center - Accepting Young Adults and Juvenile Patients

    Durham, North Carolina · Recruiting

  • Oregon Health & Science University - Accepting Adult Patients

    Portland, Oregon · Recruiting

  • Children's Hospital of Philadelphia - Accepting Young Adult and Juvenile Patients

    Philadelphia, Pennsylvania · Recruiting

  • UPMC Children's Hospital of Pittsburgh - Accepting Juvenile Patients

    Pittsburgh, Pennsylvania · Recruiting

  • UPMC Arthritis and Autoimmunity Center - Accepting Adult Patients

    Pittsburgh, Pennsylvania · Recruiting

  • Vanderbilt University Medical Center - Accepting Adult Patients

    Nashville, Tennessee · Recruiting

  • University of Texas Southwestern Medical Center - Accepting Juvenile Patients

    Dallas, Texas · Recruiting

  • Houston Methodist Hospital - Accepting Adult Patients

    Houston, Texas · Recruiting

  • University of Texas MD Anderson Cancer Center - Accepting Adult Patients

    Houston, Texas · Recruiting

  • Primary Children's Hospital/University of Utah - Accepting Juvenile Patients

    Salt Lake City, Utah · Recruiting

  • Seattle Children's Research Institute - Accepting Juvenile Patients

    Seattle, Washington · Recruiting

  • Children's Wisconsin Pediatric Rheumatology -Accepting Young Adult and Juvenile Patients

    Milwaukee, Wisconsin · Not yet recruiting

  • Universitätsmedizin Göttingen - Accepting Adult Patients

    Göttingen, Germany · Not yet recruiting

  • Ospedale Pediatrico Bambino Gesù - Accepting Young Adult and Juvenile Patients

    Roma, Italy · Recruiting

  • Kings College Hospital NHS Foundation Trust - Accepting Adult Patients

    London, United Kingdom · Recruiting

  • University College London Hospitals NHS Foundation Trust - Accepting Adult Patients

    London, United Kingdom · Recruiting

  • Great Ormond Street Hospital for Children NHS Foundation Trust - Accepting Juvenile Patients

    London, United Kingdom · Recruiting

  • Manchester Royal Infirmary - Accepting Adult Patients

    Manchester, United Kingdom · Recruiting

  • Salford Royal Hospital - Accepting Adult Patients

    Salford, United Kingdom · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.